Displaying drugs 12076 - 12100 of 12795 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Topramezone | 363.39 C16H17N3O5S |  | Topramezone is under investigation in clinical trial NCT00559520 (The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery). | Not Annotated |
| Topsalysin | Not Available |  | Investigated for use/treatment in benign prostatic hyperplasia, cancer/tumors (unspecified), prostate cancer, prostate disorders, and solid tumors. | Amino Acids, Peptides, and Proteins / Biological Factors / Membrane Proteins / Proteins / Toxins, Biological |
| Torasemide | 348.42 C16H20N4O3S |  | A diuretic used to treat hypertension and edema associated with heart failure, renal failure, or liver disease. | Sulfonamides |
| Torcetrapib | 600.4733 C26H25F9N2O4 |  | Investigated for use/treatment in peripheral vascular disease and hyperlipidemia. | Anticholesteremic Agents / Blood Pressure / Cholesterol Ester Transfer Proteins |
| Toreforant | 392.551 C23H32N6 |  | Toreforant has been used in trials studying the treatment of Asthma, Psoriasis, Hepatic Impairment, and Rheumatoid Arthritis. | Histamine Antagonists |
| Toremifene | 405.96 C26H28ClNO |  | A first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers. | Anti-Estrogens |
| Tosedostat | 406.479 C21H30N2O6 |  | Tosedostat has been used in trials studying the treatment and supportive care of AML, Leukemia, Pancreas Cancer, Multiple Myeloma, and Pancreatic Cancer, among others. Tosedostat is an inhibitor of the... | Enzyme Inhibitors |
| Tosufloxacin | 404.349 C19H15F3N4O3 |  | Not Annotated | Fluoroquinolones |
| Tosyl-D-Proline | 269.317 C12H15NO4S |  | Not Available | Not Available |
| Tosylchloramide | 205.66 C7H8ClNO2S |  | A chlorinated disinfectant of the genitals and injured skin. | Anti-Infective Agents, Local / Disinfectants / Indicators and Reagents / Oxidants |
| Tovinontrine | 394.479 C21H26N6O2 |  | Tovinontrine is an orally administered, highly selective phosphodiesterase 9 (PDE9) small molecule inhibitor. Tovinontrine is under investigation in clinical trial NCT04474314 (A Study of IMR-687 in Subjects With Sickle Cell... | Not Annotated |
| Tovorafenib | 506.29 C17H12Cl2F3N7O2S |  | A type II RAF inhibitor used to treat pediatric low-grade glioma with BRAF gene mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring / Sulfur Compounds |
| Toyocamycin | 291.2627 C12H13N5O4 |  | 4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry. | Antibiotics, Antineoplastic / Ribonucleosides |
| Tozadenant | 406.5 C19H26N4O4S |  | Tozadenant has been investigated for the basic science of Cocaine Dependence. | Heterocyclic Compounds, Fused-Ring / Thiazoles |
| TP-1287 | 481.82 C21H21ClNO8P |  | Not Annotated | Not Annotated |
| TP-252 | 919.585 C52H86MgN4O8 |  | TP-252 consists of magnesium L-lysinate bis-eicosapentaenoate, an ionizable salt of eicosapentaenoic acid (EPA), currently being investigated to treat familial adenomatous polyposis. | Dietary Fats / Dietary Fats, Unsaturated / Eicosanoids / Fats / Fatty Acids / Fatty Acids, Omega-3 / Fatty Acids, Unsaturated / Fish Oils / Lipids / Oils |
| TP-271 | 558.563 C27H31FN4O8 |  | TP-271 is under investigation in clinical trial NCT02724085 (A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271). | Naphthacenes |
| TP-3654 | 418.464 C22H25F3N4O |  | Not Annotated | Amino Acids, Peptides, and Proteins / Gastrointestinal Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Nerve Tissue Proteins / Neuropeptides / Peptide Hormones / Peptides / Proteins |
| TP-508 | Not Available |  | Investigated for use/treatment in bone fractures, diabetic foot ulcers, and wounds. | Not Available |
| TPCA-1 | 279.29 C12H10FN3O2S |  | TPCA-1 is a selective inhibitor of human IκB kinase 2 (IKK-2). | Protein Kinase Inhibitors |
| TPI-287 | 870.002 C46H63NO15 |  | Not Annotated | Cyclodecanes / Cycloparaffins / Diterpenes / Terpenes |
| TPMPA | 161.141 C6H12NO2P |  | TPMPA ((1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid) is a selective antagonist of GABAC receptors (also known as GABA-ρ or GABAA-ρ receptors). GABAC receptors are found primarily in the retina, although they may be present... | Not Annotated |
| TQS-168 | 250.345 C17H18N2 |  | Not Annotated | Blood Glucose Lowering Agents |
| Trabectedin | 761.837 C39H43N3O11S |  | An alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma). | Alkylating Drugs / Antineoplastic Agents, Alkylating / Dioxoles / Tetrahydroisoquinolines |
| Trabodenoson | 380.361 C15H20N6O6 |  | Trabodenoson has been used in trials studying the treatment of Ocular Hypertension (OHT) and Primary Open-Angle Glaucoma (POAG). | Adenosine A1 Receptor Agonists |
Displaying drugs 12076 - 12100 of 12795 in total